(Q39725547)

English

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab

scientific article published on July 2011

  • Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab

Statements

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab (English)
Christopher Carlson
Wahiba Estergard
Joonmi Oh
Joyce Suhy
Eric Siemers
Jerome Barakos
1 July 2011
396-401

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit